Published • loading... • Updated
Mass spectrometry platform could shrink cancer drug discovery cycle to four hours
Summary by Medical Xpress
1 Articles
1 Articles
Mass spectrometry platform could shrink cancer drug discovery cycle to four hours
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug discovery: identifying promising compounds that could eventually become new therapies.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
